Dr Reddy’s has commercialisation pact with Shanghai Junshi Biosciences Hyderabad-headquartered Dr Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) has obtained exclusive rights to develop and commercialise Toripalimab in 21 countries including India, South Africa, Brazil and...
Read moreDetails






